Cargando…

Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient

BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: RAMIZA RAMZA, Ramli, SHIFA, Zulkifli, BAHARUDIN, Abdullah, SAKINAH, Mohamad, NORASNIEDA, Md Shukri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Penerbit Universiti Sains Malaysia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036927/
https://www.ncbi.nlm.nih.gov/pubmed/35528810
http://dx.doi.org/10.21315/mjms2022.29.2.12
_version_ 1784693621598978048
author RAMIZA RAMZA, Ramli
SHIFA, Zulkifli
BAHARUDIN, Abdullah
SAKINAH, Mohamad
NORASNIEDA, Md Shukri
author_facet RAMIZA RAMZA, Ramli
SHIFA, Zulkifli
BAHARUDIN, Abdullah
SAKINAH, Mohamad
NORASNIEDA, Md Shukri
author_sort RAMIZA RAMZA, Ramli
collection PubMed
description BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METHODS: This cross-sectional study was conducted in the Otorhinolaryngology clinic in Universiti Sains Malaysia (USM). Seventy CRS respondents and 39 healthy participants were included. The Bahasa Malaysia translated SNOT-22 (bmSNOT-22) was produced using rigorous forward and backward translation. Statistical analyses used included feasibility, Cronbach’s alpha, intraclass correlation coefficient, Pearson’s correlation coefficient and factor analysis. RESULTS: The feasibility was 97.2% in the initial test and 100% in the retest. The Cronbach’s alpha was 0.89 in the initial test. The average intraclass correlation coefficient (ICC) was 0.90, indicating good test-retest reliability. The bmSNOT-22 discriminated between the control group and patients (t = 15.33; P < 0.001). CONCLUSION: The bmSNOT-22 is reliable, and validity established therefore recommended for Malaysia’s clinicians and researchers as a measurement tool for the outcome in sino-nasal disorders such as rhinosinusitis and nasal polyps.
format Online
Article
Text
id pubmed-9036927
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Penerbit Universiti Sains Malaysia
record_format MEDLINE/PubMed
spelling pubmed-90369272022-05-05 Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient RAMIZA RAMZA, Ramli SHIFA, Zulkifli BAHARUDIN, Abdullah SAKINAH, Mohamad NORASNIEDA, Md Shukri Malays J Med Sci Original Article BACKGROUND: Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22. METHODS: This cross-sectional study was conducted in the Otorhinolaryngology clinic in Universiti Sains Malaysia (USM). Seventy CRS respondents and 39 healthy participants were included. The Bahasa Malaysia translated SNOT-22 (bmSNOT-22) was produced using rigorous forward and backward translation. Statistical analyses used included feasibility, Cronbach’s alpha, intraclass correlation coefficient, Pearson’s correlation coefficient and factor analysis. RESULTS: The feasibility was 97.2% in the initial test and 100% in the retest. The Cronbach’s alpha was 0.89 in the initial test. The average intraclass correlation coefficient (ICC) was 0.90, indicating good test-retest reliability. The bmSNOT-22 discriminated between the control group and patients (t = 15.33; P < 0.001). CONCLUSION: The bmSNOT-22 is reliable, and validity established therefore recommended for Malaysia’s clinicians and researchers as a measurement tool for the outcome in sino-nasal disorders such as rhinosinusitis and nasal polyps. Penerbit Universiti Sains Malaysia 2022-04 2022-04-21 /pmc/articles/PMC9036927/ /pubmed/35528810 http://dx.doi.org/10.21315/mjms2022.29.2.12 Text en © Penerbit Universiti Sains Malaysia, 2022 https://creativecommons.org/licenses/by/4.0/This work is licensed under the terms of the Creative Commons Attribution (CC BY) (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Original Article
RAMIZA RAMZA, Ramli
SHIFA, Zulkifli
BAHARUDIN, Abdullah
SAKINAH, Mohamad
NORASNIEDA, Md Shukri
Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title_full Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title_fullStr Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title_full_unstemmed Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title_short Validity and Reliability Study of Bahasa Malaysia Version of Sino-Nasal Outcome Test 22 in Chronic Rhinosinusitis Patient
title_sort validity and reliability study of bahasa malaysia version of sino-nasal outcome test 22 in chronic rhinosinusitis patient
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036927/
https://www.ncbi.nlm.nih.gov/pubmed/35528810
http://dx.doi.org/10.21315/mjms2022.29.2.12
work_keys_str_mv AT ramizaramzaramli validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient
AT shifazulkifli validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient
AT baharudinabdullah validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient
AT sakinahmohamad validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient
AT norasniedamdshukri validityandreliabilitystudyofbahasamalaysiaversionofsinonasaloutcometest22inchronicrhinosinusitispatient